Vertex Pharma to Seek Speedy FDA Approval for Kidney Disease Drug From $4.9B Acquisition
Povetacicept, a Vertex Prescription drugs immunology drug designed to dam two targets, met the principle purpose of a Section 3 ...
Tag: Acquisition
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma
Day One Biopharmaceuticals is Servier’s greatest acquisition but, topping the $2.4 billion it paid to purchase Shire’s most cancers enterprise ...
Revolution Medicines’ CEO faces questions about acquisition
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition
Sanofi is boosting its vaccine portfolio and pipeline through the acquisition of Dynavax Technologies, a $2.2 billion deal bringing assets ...
BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus ...
J&J’s $3B Halda Acquisition Brings a Way to Overcome Drug Resistance in Prostate Cancer & More
Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup ...
Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major Player in Obesity Drugs & More
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar ...
DOJ: UHG, Amedisys Must Divest 164 Locations for Acquisition to Proceed
After a multi-year battle, the $3.3 billion acquisition of home health provider Amedisys by UnitedHealth Group’s Optum may finally go ...
Sanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage Vicebio
Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!